Two patients with metastatic liver cancers were treated with one or more lines of chemotherapy. Personalized combination therapy options were then suggested using a beta version of the CureMatch platform, leading to stabilization of the condition in both patients.
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.